Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegloticase Re-exposure in Refractory Gout
NCT00675103Phase 3Completed
- Sponsor
- Savient Pharmaceuticals
- Start
- May 2008
- Primary completion
- Jan 2009
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegloticase in gout, sponsored by Savient Pharmaceuticals. Started May 2008; status: completed.
02
Drugs
pegloticase
03
Conditions
gout
Beyond the preview
Go deeper on NCT00675103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00675103.